Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovaBay Pharmaceuticals | NBY | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.17 | 0.00 | 0.00 | 0.00 | 1.17 | 04:00:00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
NovaBay Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 24.03M | 20.54M | $ -6.55M | -0.46 | -3.67 | 18.76M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 674.36k | $ - | 0.00% | - | - |
NovaBay Pharmaceuticals News
PROMOTEDCanbiola Becomes Vertically Integrated with its Joint Venture with NY - SHI and Shi Farms IHNW • Mon Jul 22, 2019 7:00 AM (21 hours ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Mon Jul 15, 2019 8:31 AM (1 week ago)
NovaBay Pharmaceuticals Issues Letter to Stockholders Business Wire • Mon Jul 15, 2019 6:50 AM (1 week ago)
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) • Wed Jul 03, 2019 2:27 PM (3 weeks ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Mon Jul 01, 2019 8:33 AM (3 weeks ago)
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Business Wire • Mon Jul 01, 2019 6:50 AM (3 weeks ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Jun 26, 2019 4:32 PM (4 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.37 | 1.42 | 1.05 | 1.1895 | 373k | -0.2 | -14.60% |
| 1 Month | 1.78 | 1.92 | 1.05 | 1.5400 | 426k | -0.61 | -34.27% |
| 3 Months | 1 | 4.78 | 0.229 | 2.3115 | 3M | 0.17 | 17.00% |
| 6 Months | 1.1599 | 4.78 | 0.229 | 2.3008 | 1M | 0.0101 | 0.87% |
| 1 Year | 2.3 | 4.78 | 0.229 | 2.2915 | 683k | -1.13 | -49.13% |
| 3 Years | 2.38 | 5.29 | 0.229 | 2.4168 | 248k | -1.21 | -50.84% |
| 5 Years | 23.25 | 32.5 | 0.229 | 6.8586 | 238k | -22.08 | -94.97% |
NovaBay Pharmaceuticals Description
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing and developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX and CELLERX. |
